After CMS Coverage, Superficial Radiotherapy Firm Eyes Bigger Role In Skin Cancer Treatment
Beyond the Billing Code: What the New 2026 CMS Standards Mean for Non-Invasive Skin Cancer Treatment
Skin cancer rates continue to increase, with the American Dermatology Association most recently estimating that one in five Americans will experience skin cancer in their lifetime. As skin cancer rates rise, so does the demand for non-invasive skin cancer treatment options. Superficial radiation (SRT) technology provides an alternative to traditional Mohs surgery, giving patients an […]
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base
Proprietary cloud-based software and add-on solution designed to provide current and future SRT-100 users with enhanced workflow, operating intelligence and clinical utility Creates a scalable, recurring-revenue opportunity for Sensus tied to treatment workflows and necessary oversight services Supports improved unit economics and expands Sensus’ ability to serve Fair Deal Agreement customers and those who purchase […]
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
New financing program provides a “one-stop” pathway for practices to acquire systems through outright purchase or several attractive leasing alternatives Supports improved conversion of late-stage prospects as reimbursement clarity accelerates purchase decisions and lowers breakeven point to only one patient per month BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company […]
CMS Reimbursement for Tech-Enabled Therapies with Joseph C. Sardano from Sensus Healthcare
Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer
2026 CMS Physician Fee Schedule Final Rule provides a 300% per-fraction increase to delivery code that became effective January 1, 2026 Company enters 2026 with reimbursement certainty and strategic visibility, expects sequential-quarter revenue growth in Q1 and full-year profitability Shipped 14 SRT systems in Q4, most in December and none to its historically largest customer, […]
The Cost of Skin Cancer Treatment: What Non-Invasive Treatment Means for Healthcare
Skin cancer is the most common form of cancer in the United States. It is estimated that one in five Americans will have skin cancer before they reach the age of 70. With millions of new cases diagnosed each year, the cost of skin cancer treatment has become an important focus for many. Typical treatment includes Mohs surgery, […]
Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026
BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the company will report fourth quarter and full year 2025 financial results on Thursday, February 12, 2026. Management will hold a conference call beginning at 4:30 […]
